Volume 25, Issue 6 (11-2021)                   IBJ 2021, 25(6): 417-425 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Romi M M, Arfian N, Setyaningsih W A W, Putri R G P, Juffrie M, Sari D C R. Calcitriol Treatment Attenuates Uric Acid-Induced Kidney Injury via Super Oxide Dismutase-1 (SOD-1) Upregulation and Fibrosis Reduction. IBJ 2021; 25 (6) :417-425
URL: http://ibj.pasteur.ac.ir/article-1-3184-en.html
Background: Hyperuricemia induces nephropathy through the mediation of oxidative stress, tubular injury, inflammation, and fibrosis. The high uric acid level is associated with the reduction of vitamin D levels. However, the reno-protective effects of this vitamin in hyperuricemia condition remain unknown. This study aimed to elucidate calcitriol treatment in a uric acid-induced hyperuricemia mice model. Methods: Uric acid (125 mg/kg body weight [BW]) was administered intraperitoneally for 7 (UA7) and 14 (UA14) days. Calcitriol (0.5 mg/kg BW) was intraperitoneally injected for the following seven days, after 14 days of uric acid induction (UA14VD7 group). The control group received NaCl 0.9%, by the same route. Serum creatinine was measured using calorimetric method, and uric acid levels were assessed using enzymatic calorimetric assay. Tubular injury and fibrosis were assessed using PAS and Sirius red staining. RT-PCR and real-time reverse transcription PCR were carried out for the analyses of SOD-1, Collagen-1, and TGF-b1 mRNA expression in the kidney. Immunostaining of super oxide dismutase type 1 (SOD-1) was performed to detect its expression in the kidney. Results: Uric acid and creatinine levels markedly increased in UA14 groups, followed by an exacerbation of tubular injury. RT-PCR revealed the upregulation of Collagen-1 and TGF-b1, along with the downregulation of SOD-1. Calcitriol treatment attenuated the injury with reducing uric acid and creatinine levels, as well as tubular injury. This was associated with lower Collagen-1 and TGF-b1 mRNA expression compared to the UA7 and UA14 groups. SOD-1 was upregulated in epithelial cells in the UA14VD7 group. Conclusion: Calcitriol treatment after uric acid induction may attenuate kidney injury through upregulation of SOD-1 and downregulation of Collagen-1 and TGF-b1 gene expression.

1. Francois H, Jacquet A. Emerging strategies to preserve renal function. Journal of nephrology 2011; 24: 131-141. [DOI:10.5301/JN.2011.6355]
2. Berger L, Yu T. Renal Function in Gout . IV . An Analysis of 524 Gouty Subjects Including Long-Term. American journal of medicine 1975; 59(5): 605-613. [DOI:10.1016/0002-9343(75)90222-3]
3. Talbott JH, Terplan KL. The kidneys in gout. British medical journal 1963; 1(5332): 700. [DOI:10.1136/bmj.1.5332.700]
4. Ricotti R, Genoni G, Giglione E, Monzani A, Nugnes M, Zanetta S, Castagno M, Marolda A,Bellomo G, Bona G, Bellone S, Prodam F. High-normal estimated glomerular filtration rate and hyperuricemia positively correlate with metabolic impairment in pediatric obese patients. PLoS one 2018; 13(3):e0193755. [DOI:10.1371/journal.pone.0193755]
5. Song P, Wang H, Xia W, Chang X, Wang M, An L. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Scientific reports 2018; 8(1): 1-9. [DOI:10.1038/s41598-018-22570-9]
6. Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang X. Uric Acid, hyperuricemia and vascular diseases. Frontiers in bioscience 2012; 17: 656-669 [DOI:10.2741/3950]
7. Yang Z, Xiaohua W, Lei J, Ruoyun T, Mingxia X, Weichun H, Li F, Ping W, Junwei Y. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells. American journal of physiology-renal physiology 2010; 299(2): 336-346. [DOI:10.1152/ajprenal.00053.2010]
8. Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ. Hyperuricemia and progression of CKD in children and adolescents: the chronic kidney disease in children (CKD) cohort study. American journal of kidney diseases 2016; 66(6): 984-992. [DOI:10.1053/j.ajkd.2015.06.015]
9. Pisano A, Cernaro V, Gembillo G, D'Arrigo G, Buemi M , Bolignano D. Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients : an updated systematic review and meta-analysis. International journal of molecular sciences 2017; 18(11): 2283. [DOI:10.3390/ijms18112283]
10. Romi MM, Arfian N, Tranggono U, Setyaningsih WAW, Sari DCR. Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation. BMC Nephrology 2017; 18(1): 326. [DOI:10.1186/s12882-017-0736-x]
11. Setyaningsih WAW, Arfian N, Suryadi E, Romi MM, Tranggono U, Sari DCR. Hyperuricemia induces Wnt5a/Ror2 gene expression , epithelial-mesenchymal transition (EMT), and kidney tubular injury in mice. Iranian journal of medical sciences 2018; 43(2): 164-173.
12. Patel T, Singh AK. Role of vitamin D in chronic kidney disease. Semin nephrology 2010; 29(2): 113-121. [DOI:10.1016/j.semnephrol.2009.01.004]
13. Goncalves A, Gleize B, Roi S, Nowicki M, Dhaussy A, Huertas A, Amiot M, Reboul E. Fatty acids affect micellar properties and modulate vitamin D uptake and basolateral. Journal of nutritional biochemistry 2013; 24(10):1751-1757. [DOI:10.1016/j.jnutbio.2013.03.004]
14. Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients 2017; 9(4): 328. [DOI:10.3390/nu9040328]
15. Jhee JH, Kim H, Park S, Yun H, Jun S, Kee YK, Yoon C, Park JT, Han SH, Kang S, Yoo TH. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS one 2017; 12(2): e0171009. [DOI:10.1371/journal.pone.0171009]
16. Wimalawansa SJ, Razzaque DMS, Al-daghri NM. Calcium and vitamin d in human health: hype or real? Journal of steroid biochemistry and molecular biology 2018; 180: 4-14. [DOI:10.1016/j.jsbmb.2017.12.009]
17. Trohatou O, Tsilibary EF, Charonis A, Iatrou C, Drossopoulou G. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway. Journal of cellular and molecular medicine 2017; 21(10): 2599-2609. [DOI:10.1111/jcmm.13180]
18. Li YC. Renoprotective effects of vitamin D analogs. Kidney international 2010; 78(2):134-139. [DOI:10.1038/ki.2009.175]
19. Arfian N, Muflikhah K, Soeyono SK, Sari DCR, Tranggono U, Anggorowati N, Romi MM. Vitamin D attenuates kidney fibrosis via reducing fibroblast expansion, inflammation, and epithelial cell apoptosis. Kobe journal of medical science 2016; 62(2): E38-E44.
20. Labudzynskyi D, Latyshko N, Gudkova O. Vitamin D(3) contribution to the regulation of oxidative metabolism in the liver of diabetic mice. Ukrainian biochemical journal 2015; 87(3): 75-90. [DOI:10.15407/ubj87.03.075]
21. Kono K, Fujiii H, Nakai K, Goto S, Kitazawa R, Kitazawa S, Shinohara M, Hirata M, Fukugawa M, Nishi S. Anti oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats. American journal of nephrology 2013; 37(2):167-174. [DOI:10.1159/000346808]
22. Hsu CH, Patel SR, Young EW, Vanholder R. Effects of purine derivatives on calcitriol metabolism in rats. American physiological society 1991; 91(4-2): F596-F601. [DOI:10.1152/ajprenal.1991.260.4.F596]
23. Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J, Higashino K. Decreased serum concentrations of 1,25(OH)2-Vitamin D3 in patients with gout. Advances in experimental medicine and biology 1998; 431: 57-60. [DOI:10.1007/978-1-4615-5381-6_11]
24. Vanholder R, Patel S, Hsu CH. Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure. American society of nephrology 1993; 1: 1035-1038. [DOI:10.1681/ASN.V441035]
25. Peng H, Li H, Li C, Chao X, Zhang Q, Zhang Y. Association between vitamin D insufficiency and elevated serum uric acid among middle-aged and elderly Chinese Han Women. PLoS one 2013; 8(4): e61159. [DOI:10.1371/journal.pone.0061159]
26. Barceló A, Piérola J, Peña D, De la Peña M, Sánchez-de-la-Torre M, Montserrat JM, Marín JM, Duran J, Arqué M, Bauça JM, Barbé F. Vitamin D status and parathyroid hormone levels in patients with obstructive sleep apnea. Respiration 2013; 86(4): 295-301. [DOI:10.1159/000342748]
27. Haryono A, Nugrahaningsih DAA, Sari DCR, Romi MM, Arfian N. Reduction of serum uric acid associated with attenuation of renal injury , inflammation and macrophages M1 / M2 ratio in hyperuricemic mice model. Kobe journal of medical science 2018; 64(3): 107-114.
28. Arfian N, Budiharjo S, Kencana SMG, Susanto EH, Suhardi DY, Pramudita BD, Sari DCR, Romi MM (19-20 October 2018). Vitamin D reduces myofibroblast formation and collagen 1 expression through upregulating enos expression in kidney fibrosis model in mice. International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BIOMIC, Yogyakarta, Indonesia. https://ieeexplore.ieee.org/ document/8610552. [DOI:10.1109/BIOMIC.2018.8610552]
29. Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura J, Kaneko K, Yamashiro Y, Ogawa H, Nakao A. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney international 2004; 66(2):597-604. [DOI:10.1111/j.1523-1755.2004.00779.x]
30. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, m DN, Levey AS. Uric acid and incident kidney disease in the community. American society of nephrology 2008; 19(6): 1204-1211. [DOI:10.1681/ASN.2007101075]
31. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. New England journal of medicine 2009; 359(17): 1811-1821. [DOI:10.1056/NEJMra0800885]
32. Atalay E, Korlaelci F, Gursoy G, Karabag Y, Yildiz M, Erdogdu HI, Kivrak Y. The possible effect of vitamin d on uric acid levels in diabetic patients. World clinic journal medical sciences 2017; 1(2): 77-83. [DOI:10.5336/worldclin.2017-55375]
33. Takir M, Solak Y, Erek A, Kostek O, Oral A, Elcioglu OC, Bakan A, Afsar B, Ozkok A, Jalal D, Johnson RJ, Bahat KA, Odabas AR, Kanbay M. Association between elevated serum uric acid and vitamin d insufficiency among the middle-aged and elderly population. Turkish journal of nefrology 2016; 25(2):182-186. [DOI:10.5262/tndt.2016.1002.10]
34. Kono H, Chen C, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. Journal of clinical investigation 2010; 120(6): 1939-1949. [DOI:10.1172/JCI40124]
35. Chen W, Roncal-Jimenez C, Lanaspa M, Smits G, Conchol M, Johnson RJ, Jalal D. Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism 2014; 63(1):150-160. [DOI:10.1016/j.metabol.2013.09.018]
36. Roch-ramel F, Guisan B. Renal transport of urate in humans. News in physiological science 1999; 14: 80-84. [DOI:10.1152/physiologyonline.1999.14.2.80]
37. Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 2016; 44(3): 450-462. [DOI:10.1016/j.immuni.2016.02.015]
38. Mirkovic K, Van Den Born J, Navis G, De Borst MH. Vitamin D in chronic kidney disease: new potential for intervention. Current drug targets 2011; 12(1):42-53. [DOI:10.2174/138945011793591572]
39. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Journal of clinical investigation 2013; 123(11): 4579-4594. [DOI:10.1172/JCI67804]
40. Li Y, Spataro BC, Yang J, Dai C, Liu Y. 1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney international 2005; 68(4): 1500-1510. [DOI:10.1111/j.1523-1755.2005.00562.x]
41. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC.1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. Journal of biological chemistry 2007; 282(41): 29821-29830. [DOI:10.1074/jbc.M705495200]
42. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin - angiotensin system. Hypertension 2008; 26(2): 269-275. [DOI:10.1097/HJH.0b013e3282f240bf]
43. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, Doi T. A Vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. American journal of pathology 2001; 158(5): 1733-1741. [DOI:10.1016/S0002-9440(10)64129-6]
44. Arfian N, Ats-tsani HK, Sayekti PI, Lakabela DA, Amelia, Febriyanto T, Antonio HRP, Wibisono DP, Sari DCR. Prolonged kidney ischemia-reperfusion injury associates with inflammation, vascular remodelling, and myofibroblast formation. Journal of medical science 2018; 50: 1-14. [DOI:10.19106/JMedSci005001201801]
45. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney : effects on kidney disease. American journal of medical science 2004; 116(4): 263-72. [DOI:10.1016/j.amjmed.2003.09.034]
46. Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. American society of nephrology 2006; 17(11): 2985-2991 [DOI:10.1681/ASN.2006040356]
47. Weiwei S, Guo L, Liu G, Peng T, Li H, Xie T, Dengren L, Zhen J, Wang Y, Yang H, Yang X. Protective effect of calcitriol on podocytes in spontaneously hypertensive rat. Journal of Chinese medical association 2018; 81(8): 15691-698. [DOI:10.1016/j.jcma.2018.01.010]
48. Klaus G. Renoprotection with vitamin D: specific for diabetic nephropathy? Kidney international 2008; 73(3): 141-1438. [DOI:10.1038/sj.ki.5002693]
49. Arfian N, Kusuma MHH, Anggorowati N, Nugroho DB, Jeffilano A, Suzuki Y, Ikeda K, Emoto N. Vitamin D upregulates endothelin-1, ETBR, eNOS mRNA expression and attenuates vascular remodelling and ischemia in kidney fibrosis model in mice. Physiological research 2018; 67(Suppl 1): S137-S147. [DOI:10.33549/physiolres.933823]
50. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells. Journal of steroid biochemistry and molecular biology 2011; 118(3): 142-150. [DOI:10.1016/j.jsbmb.2009.11.004]
51. Finkel T, Holbrook NJ. Oxidants, oxidative stress, and the biology of ageing. Nature 2000; 408(6809): 239-247. [DOI:10.1038/35041687]
52. Fridovich I. Superoxide dismutases. Advances in enzymolology related areas of molecular biology 1986; 58: 61-97. [DOI:10.1002/9780470123041.ch2]
53. Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis research therapy 2015; 17(1): 98. [DOI:10.1186/s13075-015-0609-2]
54. Desideri G, Gentile R, Antonosante A, Benedetti E, Grassi D, Cristiano L, Monocchio An, Selli S, Ippoliti R, Ferri C, Borghi C, Giordano A, Cimini A. Uric acid amplifies Aamyloid effects involved in the cognitive dysfunction/dementia : evidences from an experimental model in vitro. Journal of cellular physiology 2017; 232(5): 1069-1078. [DOI:10.1002/jcp.25509]
55. Zhong W, Gu B, Gu Y, Groome LJ, Sun J, Wang Y. Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells. Journal of steroid biochemistry and molecular biology 2014; 140: 56-62. [DOI:10.1016/j.jsbmb.2013.11.017]
56. Hamden K, Carreau S, Jamoussi K, Ayadi F, Garmazi F, Mezgenni N, Elfeki A. Inhibitory effects of 125dihydroxyvitamin D3 and Ajuga iva extract on oxidative stress, toxicity, and hypo-fertility in diabetic rat testes. Journal of physiology and biochemistry 2008; 64(3): 231-240. [DOI:10.1007/BF03216108]
57. Gren A. Effects of Vitamin E , C and D supplementation on inflammation and oxidative stress in streptozotocin-induced diabetic mice. International journal for vitamim nutriton research 2013; 83(3): 9831. [DOI:10.1024/0300-9831/a000156]
58. Finch JL, Suarez EB, Husain K, Ferder L, Cardema MC, Glenn DJ, Gardner DG, Liapis H, Slatopolsky E. Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. American journal of physiology- renal physiology 2012; 302(1): F141-F149. [DOI:10.1152/ajprenal.00293.2011]
59. Sezgin G, Ozturk G, Guney S, Orhun S, Tuncdemir M. Protective effect of melatonin and 1,25-dihydroxyvitamin D3 on renal ischemia-reperfusion injury in rats. Renal failure 2013; 35(3): 374-379. [DOI:10.3109/0886022X.2012.760409]
60. Izquierdo MJ, Cavia M, Muniz P,Francisco ALM, Arias M, Santos J, Abaigar P. Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. BMC nephrology 2012; 13:159. [DOI:10.1186/1471-2369-13-159]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Biomedical Journal

Designed & Developed by : Yektaweb